These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2899171)

  • 1. Presynaptic effects of d-tubocurarine on neurotransmitter release at the neuromuscular junction of the frog.
    Matzner H; Parnas H; Parnas I
    J Physiol; 1988 Apr; 398():109-21. PubMed ID: 2899171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presynaptic action of tubocurarine during frequent stimulation of a motor nerve].
    Grigor'ev VM; Danilov AF; Skliarov AI
    Fiziol Zh SSSR Im I M Sechenova; 1989 Jan; 75(1):28-32. PubMed ID: 2538372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular transmission in a mammalian preparation in the absence of blocking drugs and the effect of D-tubocurarine.
    Hubbard JI; Wilson DF
    J Physiol; 1973 Jan; 228(2):307-25. PubMed ID: 4346989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of cholinergic agents on the release of transmitter at the frog neuromuscular junction.
    Duncan CJ; Publicover SJ
    J Physiol; 1979 Sep; 294():91-103. PubMed ID: 229216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative patterns of tubocurarine action on the synaptic potentials of frog muscle].
    Grigor'ev VM; Danilov AF; Skliarov AI
    Fiziol Zh SSSR Im I M Sechenova; 1988 Sep; 74(9):1228-34. PubMed ID: 2850942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
    Molgo J; Lemeignan M; Lechat P
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1637-9. PubMed ID: 3292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantal independence and uniformity of presynaptic release kinetics at the frog neuromuscular junction.
    Barrett EF; Stevens CF
    J Physiol; 1972 Dec; 227(3):665-89. PubMed ID: 4405552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of ketamine and hexenal on excitable membranes of a neuromuscular preparation in the frog].
    Seliverstov GA
    Farmakol Toksikol; 1984; 47(4):46-51. PubMed ID: 6090201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between quantum content and facilitation at the neuromuscular junction of the frog.
    Mallart A; Martin AR
    J Physiol; 1968 Jun; 196(3):593-604. PubMed ID: 4298821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity to Mg(2+)-and tubocurarine-block of frog neuromuscular junctions in summer and winter.
    Wernig A; Dorlöchter M; Palazis P
    Neurosci Lett; 1996 Mar; 207(1):41-4. PubMed ID: 8710205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine receptor bars and transmitter release in frog neuromuscular junctions.
    Dorlöchter M; Meurer S; Wernig A
    Neuroscience; 1993 Feb; 52(4):987-99. PubMed ID: 8450983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of tubocurarine on the quantum release of acetylcholine during the infrequent stimulation of a motor nerve].
    Grigor'ev VM; Danilov AF; Skliarov AI
    Fiziol Zh SSSR Im I M Sechenova; 1988 Oct; 74(10):1377-82. PubMed ID: 3265920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the frog neuromuscular junction for assessing the action of drugs affecting synaptic transmission.
    Payton BW
    Br J Pharmacol Chemother; 1966 Oct; 28(1):35-43. PubMed ID: 5972619
    [No Abstract]   [Full Text] [Related]  

  • 17. [Post- and presynaptic mechanisms of restoring nerve-muscle transmission with tubocurarine after the effect of an organophosphorous inhibitor of acetylcholinesterase].
    Krivoĭ II; Seĭ TP
    Dokl Akad Nauk SSSR; 1989; 306(2):499-502. PubMed ID: 2547555
    [No Abstract]   [Full Text] [Related]  

  • 18. The kinetics of quantal releases during end-plate currents at the frog neuromuscular junction.
    Van der Kloot W
    J Physiol; 1988 Aug; 402():605-26. PubMed ID: 2853224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired-pulse facilitation of transmitter release at different levels of extracellular calcium concentration.
    Mukhamedyarov MA; Zefirov AL; Palotás A
    Neurochem Res; 2006 Aug; 31(8):1055-8. PubMed ID: 16871441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical parameters of transmitter release at frog neuromuscular junctions treated with guanidine or tetraethylammonium.
    Volle RL; Branisteanu DD
    J Pharmacol Exp Ther; 1976 Jun; 197(3):653-61. PubMed ID: 6788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.